The startups that grew out of the Pfizer redundancies
By 
Julia Robinson2025-06-26T08:35:00
18 months on, three former Pfizer employees explain how they’ve seized opportunities to fill gaps in the market
In November 2023, Pfizer announced plans to discontinue its pharmaceutical sciences small molecule capabilities at its Discovery Park location in Sandwich, UK, to consolidate the facilities at two sites in the US and India. This decision, which impacted around 500 roles, was met with shock, sadness and an outpouring of support from the scientific community.